Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Innate Pharma S.a.

Start price
Target price
Perf. (%)
€2.40
22.01.24
-
22.01.25
-16.67%
24.07.24

Probably not worthwhile Investment
buy
Innate Pharma S.a.

Start price
Target price
Perf. (%)
€5.00
09.10.21
€6.00
09.10.22
-59.20%
10.10.22

Could be worthwhile Investment >10% per year
Innate Pharma S.a.

Start price
Target price
Perf. (%)
€6.60
18.09.21
€3.00
18.09.22
-26.06%
02.10.21

Lower EBIT Margin than peer group
Bad rating
Increased challenges to pay loans and raise capital
Below average Management
Innate Pharma S.a.

Start price
Target price
Perf. (%)
€5.00
04.09.21
€2.00
04.09.22
32.00%
18.09.21

Lower EBIT Margin than peer group
Bad rating
Increased challenges to pay loans and raise capital
Below average Management
buy
Innate Pharma S.a.

Start price
Target price
Perf. (%)
€3.72
22.03.21
€4.00
22.03.22
-22.04%
23.03.22

Innate Pharma S.a.

Start price
Target price
Perf. (%)
€4.22
08.09.20
-
04.11.21
-37.44%
15.07.21

Innate Pharma S.a.

Start price
Target price
Perf. (%)
€5.00
29.08.20
-
08.09.20
-15.60%
08.09.20

Innate Pharma S.a.

Start price
Target price
Perf. (%)
€5.15
26.08.20
-
29.08.20
-2.91%
29.08.20

Innate Pharma S.a.

Start price
Target price
Perf. (%)
€5.15
13.08.20
-
26.08.20
0.00%
26.08.20

Innate Pharma S.a.

Start price
Target price
Perf. (%)
€5.50
31.07.20
-
13.08.20
-6.36%
13.08.20

buy
Innate Pharma S.a.

Start price
Target price
Perf. (%)
€6.00
12.01.20
€30.00
04.11.21
-29.67%
22.11.20